ST266

DB18614InvestigationalProtein Based Therapies

ST266 is an amniotic membrane-derived cellular cytokine solution.

Code names
ST-266

What you can answer from here — as of April 23, 2025

12Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of ST266, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In